These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9619970)

  • 1. Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users.
    Pirisi M; Toniutto P; Fabris C; Lombardelli T; Falleti E; Tisminetzky SG; Baralle F; Bartoli E
    J Clin Epidemiol; 1998 May; 51(5):423-7. PubMed ID: 9619970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.
    Apichartpiyakul C; Apichartpiyakul N; Urwijitaroon Y; Gray J; Natpratan C; Katayama Y; Fujii M; Hotta H
    Jpn J Infect Dis; 1999 Jun; 52(3):121-3. PubMed ID: 10507992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area.
    Keating S; Coughlan S; Connell J; Sweeney B; Keenan E
    Ir J Med Sci; 2005; 174(1):37-41. PubMed ID: 15868888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of hepatitis C virus genotypes among intravenous heroin users in Taiwan.
    Liao KF; Lai SW; Lin CY; Huang CH; Lin YY
    Am J Med Sci; 2011 Feb; 341(2):110-2. PubMed ID: 20924285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV-RNA Pcr Positivity In Hcv Antibody Negative Patients Undergoing Haemodialysis.
    Kiani IG; Khan AN; Butt B; Sabir S; Ejaz S; Perveen A; Ghani E
    J Ayub Med Coll Abbottabad; 2018; 30(3):397-400. PubMed ID: 30465373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.
    Netski DM; Wang XH; Mehta SH; Nelson K; Celentano D; Thongsawat S; Maneekarn N; Suriyanon V; Jittiwutikorn J; Thomas DL; Ticehurst JR
    J Clin Microbiol; 2004 Apr; 42(4):1631-6. PubMed ID: 15071017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C.
    Goeser T; Seipp S; Wahl R; Müller HM; Stremmel W; Theilmann L
    J Hepatol; 1997 Mar; 26(3):498-502. PubMed ID: 9075655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil.
    Novais AC; Lopes CL; Reis NR; Silva AM; Martins RM; Souto FJ
    Mem Inst Oswaldo Cruz; 2009 Sep; 104(6):892-6. PubMed ID: 19876562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
    Matheï C; Buntinx F; Van Damme P
    J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
    [No Abstract]   [Full Text] [Related]  

  • 10. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
    Castillo I; Pardo M; Bartolomé J; Ortiz-Movilla N; Rodríguez-Iñigo E; de Lucas S; Salas C; Jiménez-Heffernan JA; Pérez-Mota A; Graus J; López-Alcorocho JM; Carreño V
    J Infect Dis; 2004 Jan; 189(1):7-14. PubMed ID: 14702147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis C virus infection and associated predictive factors: the Pakistan experience.
    Idrees M; Lal A; Malik FA; Hussain A; Rehman Iu; Akbar H; Butt S; Ali M; Ali L; Malik FA
    Infect Genet Evol; 2011 Mar; 11(2):442-5. PubMed ID: 21184846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission dynamics of hepatitis C virus among intra venous drug users in the border state of Manipur, India.
    Saha K; Firdaus R; Biswas A; Mukherjee A; Sarkar K; Chakrabarti S; Sadhukhan PC
    Infect Genet Evol; 2014 Jun; 24():57-67. PubMed ID: 24650917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
    Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
    J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis C virus in alcoholic patients: role of parenteral risk factors.
    Galperim B; Cheinquer H; Stein A; Fonseca A; Lunge V; Ikuta N
    Arq Gastroenterol; 2006; 43(2):81-4. PubMed ID: 17119659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.
    Thio CL; Nolt KR; Astemborski J; Vlahov D; Nelson KE; Thomas DL
    J Clin Microbiol; 2000 Feb; 38(2):575-7. PubMed ID: 10655348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users.
    Strasfeld L; Lo Y; Netski D; Thomas DL; Klein RS
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):356-64. PubMed ID: 12843747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.
    Stark K; Schreier E; Müller R; Wirth D; Driesel G; Bienzle U
    Scand J Infect Dis; 1995; 27(4):331-7. PubMed ID: 8658065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two successive hepatitis C virus infections in an intravenous drug user.
    Proust B; Dubois F; Bacq Y; Le Pogam S; Rogez S; Levillain R; Goudeau A
    J Clin Microbiol; 2000 Aug; 38(8):3125-7. PubMed ID: 10921996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.